icad (ICAD) Competitors $3.74 -0.14 (-3.61%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$3.82 +0.08 (+2.14%) As of 07/11/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ICAD vs. TMCI, NPCE, OM, CLPT, NNOX, ZIMV, SNWV, CATX, NYXH, and DRTSShould you be buying icad stock or one of its competitors? The main competitors of icad include Treace Medical Concepts (TMCI), NeuroPace (NPCE), Outset Medical (OM), ClearPoint Neuro (CLPT), Nano-X Imaging (NNOX), ZimVie (ZIMV), Sanuwave Health (SNWV), Perspective Therapeutics (CATX), Nyxoah (NYXH), and Alpha Tau Medical (DRTS). These companies are all part of the "medical equipment" industry. icad vs. Its Competitors Treace Medical Concepts NeuroPace Outset Medical ClearPoint Neuro Nano-X Imaging ZimVie Sanuwave Health Perspective Therapeutics Nyxoah Alpha Tau Medical Treace Medical Concepts (NASDAQ:TMCI) and icad (NASDAQ:ICAD) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation, media sentiment and analyst recommendations. Which has more volatility and risk, TMCI or ICAD? Treace Medical Concepts has a beta of 0.69, indicating that its stock price is 31% less volatile than the S&P 500. Comparatively, icad has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500. Which has stronger valuation and earnings, TMCI or ICAD? icad has lower revenue, but higher earnings than Treace Medical Concepts. icad is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTreace Medical Concepts$209.36M1.80-$55.74M-$0.85-7.06icad$19.61M5.24-$5.62M-$0.19-19.68 Is TMCI or ICAD more profitable? Treace Medical Concepts has a net margin of -25.14% compared to icad's net margin of -26.63%. icad's return on equity of -15.03% beat Treace Medical Concepts' return on equity.Company Net Margins Return on Equity Return on Assets Treace Medical Concepts-25.14% -48.69% -24.59% icad -26.63%-15.03%-11.77% Do insiders & institutionals hold more shares of TMCI or ICAD? 84.1% of Treace Medical Concepts shares are owned by institutional investors. Comparatively, 24.6% of icad shares are owned by institutional investors. 27.7% of Treace Medical Concepts shares are owned by insiders. Comparatively, 10.3% of icad shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media prefer TMCI or ICAD? In the previous week, icad had 2 more articles in the media than Treace Medical Concepts. MarketBeat recorded 5 mentions for icad and 3 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.96 beat icad's score of 0.43 indicating that Treace Medical Concepts is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive icad 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer TMCI or ICAD? Treace Medical Concepts presently has a consensus target price of $10.16, suggesting a potential upside of 69.29%. Given Treace Medical Concepts' stronger consensus rating and higher possible upside, equities research analysts plainly believe Treace Medical Concepts is more favorable than icad.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Treace Medical Concepts 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.29icad 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryTreace Medical Concepts beats icad on 9 of the 16 factors compared between the two stocks. Get icad News Delivered to You Automatically Sign up to receive the latest news and ratings for ICAD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ICAD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ICAD vs. The Competition Export to ExcelMetricicadCOMP IndustryComputer SectorNASDAQ ExchangeMarket Cap$102.74M$162.66B$27.66B$9.10BDividend YieldN/A1.31%3.12%4.02%P/E Ratio-19.6836.8436.9320.26Price / Sales5.2417.431,880.32161.28Price / CashN/A27.9037.5557.67Price / Book3.469.717.285.49Net Income-$5.62M$3.58B$767.99M$250.45M7 Day Performance-0.66%-1.87%-0.26%4.79%1 Month Performance1.63%6.52%6.06%9.59%1 Year Performance187.69%44.37%52,479.79%16.41% icad Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ICADicad0.7292 of 5 stars$3.74-3.6%N/A+187.7%$102.74M$19.61M-19.68140Gap UpTMCITreace Medical Concepts2.5161 of 5 stars$5.88+2.3%$10.16+72.7%-26.1%$361.62M$209.36M0.00250Positive NewsNPCENeuroPace3.4662 of 5 stars$11.14+4.0%$15.50+39.1%+28.0%$351.27M$79.91M0.00170High Trading VolumeOMOutset Medical1.4558 of 5 stars$19.21+0.7%$27.00+40.6%-69.2%$337.96M$113.69M0.00520Gap DownHigh Trading VolumeCLPTClearPoint Neuro1.867 of 5 stars$11.94+1.2%$25.00+109.4%+51.6%$330.27M$31.39M0.00110News CoverageAnalyst DowngradeHigh Trading VolumeNNOXNano-X Imaging1.9973 of 5 stars$5.17-1.1%$9.50+83.8%-43.2%$302.18M$11.28M0.00190Positive NewsZIMVZimVie2.0168 of 5 stars$9.35+1.0%$16.33+74.7%-51.8%$257.87M$449.75M11.721,770SNWVSanuwave HealthN/A$32.86+9.7%N/AN/A$256.24M$32.63M0.0040Positive NewsCATXPerspective Therapeutics1.0491 of 5 stars$3.44-8.5%$12.56+265.0%-69.2%$255.34MN/A0.0070NYXHNyxoah2.5356 of 5 stars$7.48+0.1%$14.50+93.9%-19.9%$254.43M$4.89M0.00110DRTSAlpha Tau Medical3.1796 of 5 stars$3.12+4.7%$8.00+156.4%+37.8%$252.76MN/A0.0080 Related Companies and Tools Related Companies Treace Medical Concepts Alternatives NeuroPace Alternatives Outset Medical Alternatives ClearPoint Neuro Alternatives Nano-X Imaging Alternatives ZimVie Alternatives Sanuwave Health Alternatives Perspective Therapeutics Alternatives Nyxoah Alternatives Alpha Tau Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ICAD) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding icad inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share icad With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ICAD Stock Alerts